Category Archives: TB

Cost of pandemic includes setbacks to South Africa tuberculosis testing, diagnoses

By on .

In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average there were tested for tuberculosis with the rapid and reliable Xpert diagnostic tool each week. An average of more than 3,700 of those tests identified active tuberculosis in people […]

Lockdowns due to COVID-19 projected to stall TB detection and treatment leading to increased incidence, deaths globally over next five years

By on .

While stay-in-place and physical distancing measures to control the spread of COVID-19 are projected to also slow the spread of other illnesses, lockdowns prompted by that pandemic will delay TB diagnoses and treatment efforts by much greater proportions, leading to rising rates of tuberculosis illness and deaths, an analysis released today shows. Focusing on impacts […]

What we’re reading: This World TB Day an ancient pandemic meets the latest global health threat

By on .

As a New Pandemic Spreads, World TB Day Reminds us of Unfinished Business – Efforts to fight the latest global health threat can come at the expense of ongoing infectious disease responses, but pathogens don’t exist in a vacuum, notes this World TB Day release from the Infectious Diseases Society of America — which produces […]

Mass TB screening with point-of-care test is cost-effective, Brazil prison study shows

By on .

Suppose you have a large group of people, confined together, considered likely to pose a threat to people outside their walls, but without the ready means to determine if they pose a threat to each other? If the space wasn’t built to contain the spread of an airborne infectious diseases, a public health disaster could […]

What we’re reading: Ways to track progress toward TB goals

By on .

Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would raise awareness of the resources needed to stem the spread of the hardest to treat forms of TB. The plan which emphasized expanded diagnosis and treatment access, also raised […]

WHO recommends expanded access to new, shorter, all oral regimens for drug-resistant TB

By on .

Incorporating patient data from national TB programs and from ongoing research, the World Health Organization has updated its guidelines on treatment for drug-resistant tuberculosis with an emphasis on accelerating access to more effective regimens that eliminate the inclusion of toxic painful injections. Among the data leading to the updated recommendation, released in a WHO Rapid […]

50th Union World Conference on Lung Health: Vaccine candidate shows effectiveness in preventing active TB disease

By on .

HYDERABAD, INDIA – The world is one major step closer to a vaccine against tuberculosis, researchers said here, with results from a clinical trial of an investigational candidate showing 50% efficacy in preventing latent TB infection from progressing to active TB disease that was sustained three years after the start of the study. “We have […]

WHO TB 2019 report: Unprecedented political commitment leads to unprecedented progress

By on .

But with a $3.3 billion shortfall in funding, gaps in treatment and prevention among the most vulnerable still take 4,000 lives a day For the first time, political commitment “at the highest level” has joined against the world’s deadliest infectious disease, the World Health Organization’s tuberculosis response leader noted today, unveiling the agency’s 2019 Global […]

China study supports use of repurposed drug, shorter regimen for MDR TB treatment

By on .

Patients treated for multidrug-resistant tuberculosis with an experimental regimen containing a repurposed drug for a year had similar rates of successful outcomes as patients treated with the standard available regimen over the course of 18 months, a study across multiple health facilities in China has found. The only significant difference between the outcomes of the […]

New TB drug approval a milestone, all agree — with caveats, some add

By on .

The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against the deadliest and most resistant form of the disease represented a major step forward on multiple fronts, international treatment advocates agree. One of only three new drugs receiving regulatory […]